27.02.2020 | Insight

HCPs raise awareness of heart disease in women during #HeartMonth

By Laura Marsh

HCPs raise awareness of heart disease in women during #HeartMonth

According to the World Health Organisation (WHO), cardiovascular diseases are the number one cause of death globally, taking an estimated 17.9 million lives each year. Originally established by President Lyndon B. Johnson in 1963, American Heart Month is intended to raise awareness about heart health and urge those around you to prevent heart disease. This awareness campaign has now been adopted by many countries around the world, with February being internationally recognised and referred to simply as ‘Heart Month’. And thanks to the powerfully connected world of social media, awareness campaigns such as Heart Month can reach more of the population than ever before.

But are awareness campaigns like this for patients only, or can healthcare professionals (HCPs) engage with and benefit from these too? Using CREATION Pinpoint® technology to analyse the unprompted conversations of HCPs globally discussing Heart Month on Twitter, we saw that HCPs in the United States in particular were actively engaging with this campaign, making up approximately two thirds of HCP authors.

#GoRedforWomen

Much HCP discussion during Heart Month was centred around heart disease in women, which is underdiagnosed, undertreated and under-researched compared to in men. Many HCPs supported public campaigns such as American Heart Association’s (AHA) ‘Go Red for Women’, which saw Twitter authors wearing red clothing, or adding a red ‘Twibbon’ to their profile in support of the commitment to end heart disease in women.

In fact, apart from the simple hashtag #HeartMonth, the most used hashtag in HCP posts was #GoRedforWomen.

Striving to end preventable deaths

During Heart Month, HCPs publicly recognised various historic developments in cardiology which have contributed to significant improvements in the treatment of heart disease. However, the message was clear – prevention is the best treatment and there still remains a lot to be done to avoid preventable deaths.

HCPs urged people to inform themselves of the risk factors for heart disease, and then take simple measures to keep themselves healthy and reduce their own risk. Some of the key ways HCPs suggested to lower the risk of heart disease included making dietary changes, exercising more and receiving recommended vaccinations.

Who was the most influential?

One author who was notably influential within the Heart Month online conversation amongst HCPs was US cardiologist Martha Gulati (@DrMarthaGulati). She was well respected by her HCP peers within the Heart Month conversation, who frequently retweeted her posts and mentioned her name within discussions. Many HCPs including Dr Gulati raised awareness of the symptoms of heart failure in women, and how these differ to the common male

Pharma companies contribute with above-brand messaging

Awareness days also offer a great opportunity for pharma companies to demonstrate interests aligned with the cares of HCPs and patients in the therapy area. Boehringer Ingelheim (@boehringerus) received positive engagement from members of the public who retweeted their post encouraging patients to speak with their doctor about managing their whole health, including diabetes and kidney disease.

By engaging with the wider disease area, outside of brand messaging, pharma companies are more likely to be seen by HCPs as having a genuine motivation to improve patient care. For example, during Heart Month, Johnson & Johnson (@JNJNursing) authored a post celebrating influential nurse Elizabeth Mikula and her transformational work in cardiology, which was shared by eight US nurses.

Throughout February, we have seen HCPs engaging with Heart Month by raising awareness, encouraging the prevention of heart disease, and standing in solidarity with patients. HCPs across the globe added a valuable voice to the Heart Month discussion on Twitter, and alongside patients, professional organisations and pharma companies, demonstrated their caring attitude towards the therapy area, engaging with campaigns striving for tangible change.

View all articles >

Meet the Author

Laura Marsh

Suggested next


10.11.2023 | Article

EASD 2023: what drove online conversation among HCPs and people with diabetes?

There were hundreds of presentations, posters and spotlight talks over the five days

By Jamie Doggett

FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

11.02.2020 | Article

FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

By Nathan Cripps

View all articles >